FEATURED ARTICLES

• A Better Approach To eConsent: Flexible Consent Through Enabling Technologies

  Electronic consent, or eConsent, digitalizes the trial participant consent process through increasingly simplified, interactive, educational models designed to improve comprehension and boost engagement.

• Effective Use Of IRT In Decentralized And Hybrid Clinical Trials

  Discover how IRTs are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.

• YPrime eConsent: Putting Power In The Hands Of Patien

  At YPrime, we have a passion for empowering the patient through their clinical trial journey and eliminating the barriers and friction that get in their way.

• The Revival of eConsent

  The clinical research industry has been reluctant to adopt eConsent for several reasons, not least of which included having to disrupt already stressed and short-staffed work environments to implement new technology. Read how the industry should continue exploring and implementing digital technologies in earnest.

   
• Minimizing Hurdles For Patients During The eConsent Process

  Learn how eConsent digitalizes the trial participant consent process through increasingly simplified models designed to improve comprehension and boost engagement.

• How Did The Pandemic Impact Clinical Trial Sites?

  When the COVID-19 pandemic hit the U.S. in March 2020, many drug developers were caught by surprise. With clinics overwhelmed by COVID patients and the reluctance of some patients to venture out to those clinics, many trials faced the prospect of being delayed or canceled. Decentralized clinical trials (DCTs) and hybrid trials, which can take studies from the clinics to the patients, seemed to be the solution to keep things on track.

• How Is The Expense Of DCTs Impacting Clinical Trial Sites?

  When the COVID-19 pandemic hit the U.S. in March 2020, many drug developers were caught by surprise. With clinics overwhelmed by COVID patients and the reluctance of some patients to venture out to those clinics, many trials faced the prospect of being delayed or canceled. Decentralized clinical trials (DCTs) and hybrid trials, which can take studies from the clinics to the patients, seemed to be the solution to keep things on track.

• How Can You Help Sites Manage Training And Education On DCT Technologies?

  When the COVID-19 pandemic hit the U.S. in March 2020, many drug developers were caught by surprise. With clinics overwhelmed by COVID patients and the reluctance of some patients to venture out to those clinics, many trials faced the prospect of being delayed or canceled. Decentralized clinical trials (DCTs) and hybrid trials, which can take studies from the clinics to the patients, seemed to be the solution to keep things on track.

• Are Clinical Sites Seeing Cost Reductions As A Result Of DCTs?

  When the COVID-19 pandemic hit the U.S. in March 2020, many drug developers were caught by surprise. With clinics overwhelmed by COVID patients and the reluctance of some patients to venture out to those clinics, many trials faced the prospect of being delayed or canceled. Decentralized clinical trials (DCTs) and hybrid trials, which can take studies from the clinics to the patients, seemed to be the solution to keep things on track.

• Is The Stress Level At Clinical Sites Going Thru The Roof?

  When the COVID-19 pandemic hit the U.S. in March 2020, many drug developers were caught by surprise. With clinics overwhelmed by COVID patients and the reluctance of some patients to venture out to those clinics, many trials faced the prospect of being delayed or canceled. Decentralized clinical trials (DCTs) and hybrid trials, which can take studies from the clinics to the patients, seemed to be the solution to keep things on track.

• Simple And Cost-Effective Ways To Engage Patients Using eCOA And IRT

  Today, patients are exposed to sophisticated technology, which presents a huge opportunity to incorporate patient engagement into clinical trials and elevate patient engagement efforts in ongoing clinical trials. Consider some common elements when inciating patient engagement during clinical development.

• Experience The YPrime Difference

  At YPrime, we’re here to help you make a positive impact by bringing live-changing therapies to market.

• Progress On Modern Approaches For Clinical Trial Design, Execution, And Wider Engagement

  As the clinical research ecosystem continues to expand and include the perspectives of research partners, stakeholders, and patients and caregivers, learn why collaboration and connection is essential to future clinical trial success and next-generation medicine.

• Seek Patient Insights To Develop Effective Decentralized Clinical Trial Strategies

  Learn how supporting patients’ participation in completing study requirements can ease the burden on both patients and their care partners when it comes to decentralized trials.

• Applying Consumer Engagement Strategies To eClinical Technology

  When it comes to patient engagement, the experience and technology gaps apparent in the clinical trial space have resulted in a lag for virtual technologies that offer comparable functionality to those pioneered by other sectors.

• Applying A Consumer Approach To eClinical Technology

  This webinar addresses lessons the eClinical space can learn from consumer engagement, how to "scale" empathy using eClinical applications, and how consumer engagement methods can be used in eClinical applications to engage, incentivize, and motivate patients in clinical trials

• Improving The Patient Experience In Clinical Trials

  Technology is critical to clinical trial efficiency and data quality, particularly for supporting the increased operational complexities of research. Discover ways to think broadly about the effective implementation of technology.

• eClinical Shifts Left

  Find out how the shift left testing principles focus on continuous integration and delivery, a practice designed to find and prevent defects early in the software delivery process.

• Optimizing Decentralized Clinical Trial Strategy And Technologies

  Learn why DCT solutions must be considered while identifying and prioritizing how a strategy or technology grants efficiencies in one area while generating complex issues in another.

• Data Governance In The Clinical Trial Ecosystem

  Data governance aligns people, processes, and information technology in order to optimize the use and value of data across a business enterprise. Discover how this formal practice helps sponsors collect, integrate, and analyze data strategically to advance their drug development programs.